S100A8/S100A9 serum levels correlate closely with response to drug treatment and disease activity and therefore might be an additional measurement for monitoring anti-inflammatory treatment of individual patients with SJIA (62, 77). The gene discussed is S100A8; the disease is systemic-onset juvenile idiopathic arthritis.